Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

Dana-farber Partners Cancercare Inc

Neither a doctor nor a teaching hospital

Research payments

$1,071,600

74 payments

Through program year 2024, Dana-farber Partners Cancercare Inc is reported as receiving $1,071,600 in research payments, across 74 payments.

By program year

6 rows
Year Kind Amount Payments
2024 Research $25,633 4
2023 Research $16,027 3
2022 Research $380,039 47
2021 Research $246,110 16
2020 Research $12,244 2
2019 Research $391,547 2

Breakdown

Who paid Research payments · program years 2019–2024
  1. Daiichi Sankyo Inc. $391,547 2 payments
  2. Bayer HealthCare Pharmaceuticals Inc. $290,559 26 payments
  3. Genentech, Inc. $263,808 29 payments
  4. Roche Products Limited $51,505 4 payments
  5. Hoffmann-La Roche Limited $29,423 5 payments
  6. QED Therapeutics, Inc. $20,949 5 payments
  7. Immunomedics, Inc. $12,244 2 payments
  8. Merck Sharp & Dohme Corporation $11,565 1 payment
Studies the money was for Research payments · program years 2019–2024
  1. U31402-A-U102 $385,158 1 payment
  2. Bay88-8223 Alpharadin Combo with abiraterone in CRPC $207,880 7 payments
  3. PH I of Fcrh5 Cd3 in Multiple Myeloma $122,455 3 payments
  4. PH 2 Randomized Poc Study of PCV in 1L Melanoma $64,570 10 payments
  5. Morpheus Pancreatic $40,169 1 payment
  6. BAY 1841788 mHSPC $34,765 8 payments
  7. Ph1b Open Label Dose Escalation Study $34,210 2 payments
  8. Morpheus CRC $29,423 5 payments
  9. BAY 888223, A phase III randomized, double-blind, placebo-controlled trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone in the treatment of asymptomatic or mildly symptomatic chemotherapy-nave subjects with $25,633 4 payments
  10. PH Ia Ib Personalized Cancer Vaccine Atezolizumabb $23,800 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record